News

Dr. Virginia Pascual, the Drukier Director of the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, was awarded the Lupus Insight Prize on June 15 by the Lupus Research Alliance. 

Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer’s disease.

Last spring, veteran pharmaceutical executive and entrepreneur Dr. William Polvino was tapped as CEO of Bridge Medicines, a company established in October 2016 to further the development of drugs nurtured by the Tri-Institutional Therapeutics Discovery Institute. 

Weill Cornell Medicine has received a $45.3 million renewal grant from the National Institutes of Health’s Clinical and Translational Science Awards Program to continue funding its multi-institutional Clinical and Translational Science Center until 2022.

Dr. Michael LeVine, (PhD ’16), grew up in Taunton, Massachusetts, a city about 40 miles south of Boston. One of the oldest towns in the United States — founded in the 1630s — Taunton in recent decades has suffered through a very modern scourge: the staggering opioid epidemic that has devastated so many communities nationwide.

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer research.

Though medicine has made important strides in treating cardiac patients in recent years, there’s still no cure for cardiovascular disease — a broad group of disorders that claim nearly 18 million lives around the globe annually, a number that the World Health Organization predicts will grow to almost 23.6 million by 2030.

The complex life cycle of the parasite that causes malaria has made it a difficult foe to beat. But new insights on how the parasite is transmitted from humans to the mosquitoes that spread malaria may lead to new ways to control this deadly disease.

Actress Angelina Jolie’s 2013 announcement detailing her decision to undergo a mastectomy to reduce her risk of developing breast cancer likely inspired more women in English-speaking countries to do the same.

On a Tuesday in early June, just days before summer break, dozens of third-year medical students gathered in the Belfer Research Building to present findings from independent research projects they’d been working on since February.

Errors in the regulation of gene expression may contribute to the development of a common form of blood cancer and point to potential treatment strategies, according to a new study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Dr. Olivier Elemento, a renowned computational biologist and leader in the field of computational genomics and biomedicine, has been named director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine.

Nano-sized sensors developed by Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers can measure lipids, or fat molecules, in special compartments within live cells.

A new study finds that it isn’t just the amount of time spent sitting, but also the way in which sitting time is accumulated during the day, that can affect risk of early death.

Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from the National Cancer Institute to improve the detection, diagnosis and treatment of prostate cancer. 

Nerve cells in the gut play a crucial role in the body’s ability to marshal an immune response to infection.

Annual mammograms for women beginning at age 40 prevent the greatest number of breast cancer deaths.

States that require prescribers to register for prescription drug monitoring programs have seen a reduction in the number of prescriptions issued for Schedule II opioids to Medicaid enrollees by up to 10 percent, according to research from Weill Cornell Medicine investigators.

A compound used in traditional Chinese medicine to lower blood pressure also strongly combats Zika virus infection of the brain, and may protect against Zika-associated birth defects, according to a new study by Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center scientists. 

Dr. Michael G. Stewart is taking on an expanded role as vice dean at Weill Cornell Medicine, and Dr. Peter N. Schlegel has been appointed senior associate dean for clinical affairs.